China (Mainland)
Diamondsupplier 
Factory Supply Sorafenib Tosylate CAS: 475207-59-1 CAS NO.475207-59-1
- FOB Price: USD: 20.00-20.00 /Metric Ton Get Latest Price
- Min.Order: 1 Kilogram
- Payment Terms: L/C,D/A,D/P,T/T,MoneyGram,Other
- Available Specifications:
99%(500-1000)Metric Ton
- Product Details
Keywords
- Sorafenib Tosylate
- Sorafenib
- 475207-59-1
Quick Details
- ProName: Factory Supply Sorafenib Tosylate CAS:...
- CasNo: 475207-59-1
- Molecular Formula: C28H24ClF3N4O6S
- Appearance: white powder
- Application: kidney cancer
- DeliveryTime: in 7 days
- PackAge: 1KG/bag. 25KG/drum
- Port: Shanghai/Beijing/Tianjin
- ProductionCapacity: 10 Metric Ton/Year
- Purity: 99%
- Storage: Room temperature
- Transportation: Regular transporation
- LimitNum: 1 Kilogram
- Related Substances: 0.1%
- Residue on Ignition: 0.5%
- Heavy Metal: 10ppm
- Valid Period: 3 years
Superiority
Why is SINOWAY:
1) Specialized in pharmaceutical and healthcare industrial for 34 years.
2) ISO 9001:2015 & SGS audited supplier .
3) Accept various payment terms : T.T 30-60 days.
4) We have warehouse in USA with quickly shipment .
5) We can do different terms of FOB ,CIF/CIP ,DDP ...
Our Advantage of Sorafenib Tosylate CAS: 475207-59-1
Best Quality and Competitive price
Details
the information of Sorafenib Tosylate CAS: 475207-59-1:
|
Product name |
Sorafenib Tosylate | |
|
CAS No. |
475207-59-1 | |
|
Molecular Formula |
|
|
|
Molecular Weight |
637.03 | |
|
Quality Standard |
99% up, Medicine Grade |
|
|
Appearance |
White powder |
The COA of Sorafenib Tosylate CAS: 475207-59-1:
The use of Sorafenib Tosylate CAS: 475207-59-1: :
Sorafenib toluenesulfonic acid has dual antitumor effects. On the one hand, it can directly inhibit tumor growth by inhibiting RAF/MEK/ERK signaling pathway.On the other hand, it can indirectly inhibit tumor cell growth by inhibiting VEGFR and PDGFRChemicalbook by blocking tumor angiogenesis.Sorafenib toluenesulfonic acid is the most effective systemic drug to date for the treatment of advanced liver cancer and is likely to become the new standard for the treatment of the disease.
